Placebo Versus Best-Available-Therapy Control Group in Clinical Trials for Pharmacologic Therapies: Which Is Better?

Proceedings of the American Thoracic Society
doi 10.1513/pats.200706-073jk
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Thoracic Society

Related search

JAK Inhibition With Ruxolitinib Versus Best Available Therapy for Myelofibrosis

New England Journal of Medicine
Medicine
2012English

P3.01-115 Liposomal Paclitaxel Versus Gemcitabine: Which Is Better?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Control of Cystic Artery During Laparoscopic Cholecystectomy: Clips Versus Ultrasonic Energy Devices Which Is Better?

International Surgery Journal
2017English

Lung Cancer: One Therapy Is Better Than Two Sequential Therapies

Cancer therapy & Oncology International Journal
2018English

Placebo Response in Antipsychotic Clinical Trials

JAMA Psychiatry
MedicinePsychiatryMental Health
2014English

Manual Vacuum Aspiration Versus Sharp Curettage for Incomplete Abortion: Which One Is Better?

Indonesian Journal of Obstetrics and Gynecology
2019English

Programmed Versus Natural Frozen Embryo Transfer: Which Is the Best Nest?

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2018English

Clinical Trials of Neuroprotective Therapies

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2007English

Placebo-Controlled Trials in Pediatrics and the Child’s Best Interest

Italian Journal of Pediatrics
Child HealthPediatricsPerinatology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy